CHUGAI PHARMACEUTICAL CO., LTD. Logo

CHUGAI PHARMACEUTICAL CO., LTD.

A research-driven pharmaceutical company developing innovative medical products.

4519 | T

Overview

Corporate Details

ISIN(s):
JP3519400000
LEI:
Country:
Japan
Address:
北区浮間五丁目5番1号

Description

Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-25 08:42
確認書
Japanese 9.6 KB
2025-07-25 08:40
半期報告書-第115期(2025/01/01-2025/12/31)
Japanese 298.8 KB
2025-04-22 09:07
訂正臨時報告書
Japanese 39.1 KB
2025-03-28 06:43
臨時報告書
Japanese 27.8 KB
2025-03-27 08:12
臨時報告書
Japanese 39.7 KB
2025-03-27 07:57
内部統制報告書-第114期(2024/01/01-2024/12/31)
Japanese 24.8 KB
2025-03-27 07:50
確認書
Japanese 9.6 KB
2025-03-27 07:48
有価証券報告書-第114期(2024/01/01-2024/12/31)
Japanese 3.3 MB
2024-07-26 08:02
確認書
Japanese 9.6 KB
2024-07-26 08:01
半期報告書-第114期(2024/01/01-2024/12/31)
Japanese 330.6 KB
2024-07-26 07:35
確認書
Japanese 9.6 KB
2024-07-26 07:30
訂正有価証券報告書-第113期(2023/01/01-2023/12/31)
Japanese 1.8 MB
2024-04-25 08:09
確認書
Japanese 9.6 KB
2024-04-25 08:07
四半期報告書-第114期第1四半期(2024/01/01-2024/03/31)
Japanese 272.0 KB
2024-04-24 08:21
確認書
Japanese 9.6 KB

Automate Your Workflow. Get a real-time feed of all CHUGAI PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHUGAI PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHUGAI PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.